It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its...

A big part of the EU-US productivity gap is due to the EU investing less in ICT-related tangible and intangible capital. These lower investments are partly explained by EU digital regulations limiting companies' access to modern endowments like data. Limits to these endowments push EU firms...

It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its...